Matthew Healy

Title: Matthew Healy: Innovator in Cardiovascular Research

Introduction

Matthew Healy is a prominent inventor based in Tarrytown, NY (US). He has made significant contributions to the field of cardiovascular research, holding 2 patents that focus on innovative methods and compositions related to B4GALT1 variants.

Latest Patents

His latest patents include "B4GALT1 Variants And Uses Thereof" and "B4GALT1 cDNA variants and compositions comprising the same." These patents detail various aspects of B4GALT1 genomic, mRNA, and cDNA nucleic acid molecules, as well as polypeptides. They also outline methods for detecting the presence of these molecules, modulating endogenous B4GALT1, and assessing the risk of developing cardiovascular conditions. Furthermore, the patents provide methods for treating cardiovascular conditions, showcasing the potential impact of his work on healthcare.

Career Highlights

Matthew Healy has worked with notable organizations such as Regeneron Pharmaceuticals, Inc. and the University System of Maryland. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his coworkers include May Montasser and Cristopher Van Hout. Their collaborative efforts have further advanced the research and development of cardiovascular treatments.

Conclusion

Matthew Healy's innovative work in the field of cardiovascular research highlights his dedication to improving healthcare outcomes. His patents and collaborations reflect his commitment to advancing scientific knowledge and developing effective treatments for cardiovascular conditions.